(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LUMIPORE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

LUMIPORE

ST13

US500000079366928

Classe

9, 10

Pedido

79366928

Registro

7554064

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 10

Data de depósito

14/02/2023

Data de registro

05/11/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/11/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

BE

Examinador

MAHMOUDI, MARIAM AZIZ

Unidade examinadora

M60

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Trince, besloten vennootschap

Representantes

Clifford D Hyra Fresh IP PLC

Classificação técnica

Classes Nice

Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Scientific apparatus and instruments for cell modificationtransfection devices; scientific apparatus and instruments for scientific research and developmenttransfection devices for cell modification; scientific apparatus and instruments for scientific research and developmentdevices for transfection of cells for clinical research and medical research; Scientific apparatus and instruments for use in cell therapystem cell therapytissue engineering and regenerative medicinedevices for the ablation and killing of cells; laboratory instruments for use in immunotherapy and cancer treatmenttransfection devices; laboratory instruments for use in tissue engineering and regenerative medicinedevices for transfectioncell and tissue ablation and cell killing; laboratory instruments for the development of gene modified cell therapiestransfection devices; laboratory equipment for modification of cells for research related to the treatment of diseasesdevices for transfectioncell ablation and cell killing; equipment for cell manipulationdevices for transfectioncell ablation and cell killing

Classe 10

Medical devicestransfection devices used for cell therapy treatments; Medical devicesinstruments used for immunotherapy treatments and for modifying cells for the treatment of cancer and other diseases and medical conditions related to tissue engineering and regenerative medicine namelydevices for transfectioncell ablation and cell killing; apparatus for the regeneration of stem cells and tissues for medical purpose; medical apparatus and instruments for use in cell therapystem cell therapytissue engineering and regenerative medicinedevices for transfectioncell ablation and cell killing; unfilled cartridges for cell transfectioncell ablation and cell killing for medical diagnostic purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/04/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/04/2025

FIMP

FINAL DISPOSITION PROCESSED

07/04/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/02/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/11/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/11/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

20/09/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/09/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/09/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

20/08/2024

PUBO

PUBLISHED FOR OPPOSITION

20/08/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

31/07/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/07/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/07/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/07/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/07/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/05/2024

GNFR

FINAL REFUSAL E-MAILED

01/05/2024

CNFR

FINAL REFUSAL WRITTEN

01/05/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/04/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/04/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

21/12/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

21/12/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/12/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/12/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

21/12/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

21/12/2023

RFNT

REFUSAL PROCESSED BY IB

12/12/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

21/11/2023

RFRR

REFUSAL PROCESSED BY MPU

21/11/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

18/11/2023

CNRT

NON-FINAL ACTION WRITTEN

17/11/2023

DOCK

ASSIGNED TO EXAMINER

14/11/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/06/2023

MAFR

APPLICATION FILING RECEIPT MAILED

14/04/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/04/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/04/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LUMIPORE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.